1. Home
  2. PZZA vs WVE Comparison

PZZA vs WVE Comparison

Compare PZZA & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PZZA
  • WVE
  • Stock Information
  • Founded
  • PZZA 1984
  • WVE 2012
  • Country
  • PZZA United States
  • WVE Singapore
  • Employees
  • PZZA N/A
  • WVE N/A
  • Industry
  • PZZA Restaurants
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PZZA Consumer Discretionary
  • WVE Health Care
  • Exchange
  • PZZA Nasdaq
  • WVE Nasdaq
  • Market Cap
  • PZZA 1.1B
  • WVE 915.6M
  • IPO Year
  • PZZA 1993
  • WVE 2015
  • Fundamental
  • Price
  • PZZA $48.34
  • WVE $6.50
  • Analyst Decision
  • PZZA Buy
  • WVE Strong Buy
  • Analyst Count
  • PZZA 12
  • WVE 13
  • Target Price
  • PZZA $51.36
  • WVE $20.15
  • AVG Volume (30 Days)
  • PZZA 1.4M
  • WVE 1.0M
  • Earning Date
  • PZZA 08-07-2025
  • WVE 08-07-2025
  • Dividend Yield
  • PZZA 3.79%
  • WVE N/A
  • EPS Growth
  • PZZA 4.47
  • WVE N/A
  • EPS
  • PZZA 2.37
  • WVE N/A
  • Revenue
  • PZZA $2,063,780,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • PZZA $4.30
  • WVE N/A
  • Revenue Next Year
  • PZZA $3.68
  • WVE $1.94
  • P/E Ratio
  • PZZA $20.49
  • WVE N/A
  • Revenue Growth
  • PZZA N/A
  • WVE N/A
  • 52 Week Low
  • PZZA $30.16
  • WVE $4.87
  • 52 Week High
  • PZZA $60.75
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • PZZA 58.08
  • WVE 45.10
  • Support Level
  • PZZA $47.61
  • WVE $6.67
  • Resistance Level
  • PZZA $50.00
  • WVE $7.10
  • Average True Range (ATR)
  • PZZA 2.46
  • WVE 0.38
  • MACD
  • PZZA -0.53
  • WVE -0.02
  • Stochastic Oscillator
  • PZZA 28.53
  • WVE 7.77

About PZZA Papa John's International Inc.

Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: